SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-102886
Filing Date
2024-04-19
Accepted
2024-04-19 16:12:02
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-19

Document Format Files

Seq Description Document Type Size
1 ARS d601296dars.pdf ARS 4356299
  Complete submission text file 0001193125-24-102886.txt   5956320
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38978 | Film No.: 24857877
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)